Skip to content
News
Careers
Donate
Contact Us
Twitter Icon
Facebook Icon
Linked In Icon
News
Careers
Donate
Contact Us
Twitter Icon
Facebook Icon
Linked In Icon
ashm.org.au
Resources
Training
Prescriber Maps
ashm.org.au
Resources
Training
Prescriber Maps
Search
ashm.org.au
Resources
Training
Prescriber Maps
ashm.org.au
Resources
Training
Prescriber Maps
HIV Management Guide for Clinical Care
HIV Management Guide for Clinical Care
Home
Introduction
About
HIV Management
Epidemiology & Natural History
Epidemiology of HIV infection in Australasia
Natural history of HIV infection
Virology & Immunology
Basic HIV virology
HIV immunology
Diagnostic & Monitoring Tests
Virological tests
Immunological tests
Primary HIV Infection
HIV-infectious Disease & Cancer
Respiratory tract infections in patients with HIV infection
Tuberculosis
Non-tuberculous mycobacterial infections in people with HIV infection
Opportunistic infections of the gastrointestinal tract
Ocular disease in patients with HIV infection
Opportunistic infections acquired in localised geographical regions of the world
Human papillomavirus-associated malignancy
Skin disease
Opportunistic Infections of the Central Nervous System
Other HIV-Associated Disease
Haematological disorders
Heart disease
Rheumatological disease
Neurological Disease
Pulmonary Disease: Including Sarcoidosis and COPD
Co-infections
Sexually transmissible infections among people with HIV infection
Hepatitis C virus
Hepatitis B virus
Hepatitis E virus
HTLV-1
ARV Drugs & other Therapies
Antiretroviral drugs
Initiation of antiretroviral therapy in the treatment-naïve patient
Long-term management of antiretroviral therapy
Immune reconstitution inflammatory syndrome and other immune reconstitution disorders
Antiretroviral Therapy Guidelines
Drug-drug interactions in patients with HIV infection
Adverse reactions to antiretroviral and other drugs in people with HIV infection
Vaccines in people with HIV infection
Co-Morbidities
Atherosclerotic vascular disease
Endocrine disorders
Bone disease in patients with HIV infection
Renal disease
Special Patient Populations
Ageing with HIV infection
Psychiatric disorders in people with HIV infection
HIV infection in Adolescents Transitioning to Adult Care
HIV infection in Aboriginal and Torres Strait Islander people
Pregnant Women
Nurses & Midwives
New HIV Diagnosis
Late presentation of new HIV diagnosis
Partner notification and contact tracing
Key Affected Populations
Pregnancy and Midwifery considerations in HIV
Paediatric issues
Client education
Nursing considerations of major clinical issues
HIV-associated neurocognitive disorder
Adherence support
Health promotion
Clinical supervision for nurses in the HIV sector
Biomedical HIV prevention
Evolving roles of nurses in HIV care
Nursing ethics in the care of people with HIV
Mpox and COVID-19
Biomedical prevention
PEP and PrEP
Microbicides
ASHM PrEP Guidelines
Acknowledgement
Glossary of Terms
Contact Us
Home
Introduction
About
HIV Management
Epidemiology & Natural History
Epidemiology of HIV infection in Australasia
Natural history of HIV infection
Virology & Immunology
Basic HIV virology
HIV immunology
Diagnostic & Monitoring Tests
Virological tests
Immunological tests
Primary HIV Infection
HIV-infectious Disease & Cancer
Respiratory tract infections in patients with HIV infection
Tuberculosis
Non-tuberculous mycobacterial infections in people with HIV infection
Opportunistic infections of the gastrointestinal tract
Ocular disease in patients with HIV infection
Opportunistic infections acquired in localised geographical regions of the world
Human papillomavirus-associated malignancy
Skin disease
Opportunistic Infections of the Central Nervous System
Other HIV-Associated Disease
Haematological disorders
Heart disease
Rheumatological disease
Neurological Disease
Pulmonary Disease: Including Sarcoidosis and COPD
Co-infections
Sexually transmissible infections among people with HIV infection
Hepatitis C virus
Hepatitis B virus
Hepatitis E virus
HTLV-1
ARV Drugs & other Therapies
Antiretroviral drugs
Initiation of antiretroviral therapy in the treatment-naïve patient
Long-term management of antiretroviral therapy
Immune reconstitution inflammatory syndrome and other immune reconstitution disorders
Antiretroviral Therapy Guidelines
Drug-drug interactions in patients with HIV infection
Adverse reactions to antiretroviral and other drugs in people with HIV infection
Vaccines in people with HIV infection
Co-Morbidities
Atherosclerotic vascular disease
Endocrine disorders
Bone disease in patients with HIV infection
Renal disease
Special Patient Populations
Ageing with HIV infection
Psychiatric disorders in people with HIV infection
HIV infection in Adolescents Transitioning to Adult Care
HIV infection in Aboriginal and Torres Strait Islander people
Pregnant Women
Nurses & Midwives
New HIV Diagnosis
Late presentation of new HIV diagnosis
Partner notification and contact tracing
Key Affected Populations
Pregnancy and Midwifery considerations in HIV
Paediatric issues
Client education
Nursing considerations of major clinical issues
HIV-associated neurocognitive disorder
Adherence support
Health promotion
Clinical supervision for nurses in the HIV sector
Biomedical HIV prevention
Evolving roles of nurses in HIV care
Nursing ethics in the care of people with HIV
Mpox and COVID-19
Biomedical prevention
PEP and PrEP
Microbicides
ASHM PrEP Guidelines
Acknowledgement
Glossary of Terms
Contact Us
Search
Acknowledgements
Contact Us
Acknowledgements
Contact Us
Acknowledgements
Contact Us
Acknowledgements
Contact Us
Nurses & Midwives
Guidelines
>
Resources
Management > Nurses & Midwives > Resources
Sections
Sections
Menu
Clinical supervision for nurses in the HIV sector
What is clinical supervision for?
Confidentiality
Why should nurses and midwives working in the HIV sector be provided with routine clinical supervision?
Remote and Indigenous communities
The impact of COVID-19
Conclusion
Resources
References
Resources
Australian Clinical Supervision Association
Prev
Previous
Next
Next
Scroll to Top
